Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

U.S. Market Analysis & Valuation

UpdatedDec 31, 2025
DataAggregated Company Financials
Companies7899
  • 7D-0.5%
  • 3M1.6%
  • 1Y16.9%
  • YTD16.7%

Over the last 7 days, the market has remained flat, with no particular sector making any big moves this week. As for the longer term, the market has risen 17% in the past 12 months. As for the next few years, earnings are expected to grow by 16% per annum.

Trending IndustriesOil and GasGoldBiotechSoftwareRenewable Energy

Market Valuation and Performance

Has the U.S. Market valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 31 Dec 2025US$72.3tUS$23.2tUS$2.3t19x31.6x3.1x
Fri, 28 Nov 2025US$71.3tUS$23.1tUS$2.3t18.7x31.3x3.1x
Sun, 26 Oct 2025US$71.6tUS$22.8tUS$2.3t18.9x31.8x3.1x
Tue, 23 Sep 2025US$70.7tUS$22.9tUS$2.2t19.3x32.3x3.1x
Thu, 21 Aug 2025US$67.1tUS$23.0tUS$2.2t18.7x31.1x2.9x
Sat, 19 Jul 2025US$66.0tUS$22.5tUS$2.1t18.7x31.4x2.9x
Mon, 16 Jun 2025US$62.3tUS$22.5tUS$2.1t17.7x29.7x2.8x
Wed, 14 May 2025US$61.0tUS$22.4tUS$2.1t17.9x29.1x2.7x
Fri, 11 Apr 2025US$56.3tUS$21.9tUS$2.1t16x27.4x2.6x
Sun, 09 Mar 2025US$60.2tUS$21.9tUS$2.0t17.5x29.3x2.7x
Tue, 04 Feb 2025US$63.8tUS$22.1tUS$2.0t18.5x31.8x2.9x
Thu, 02 Jan 2025US$61.7tUS$22.0tUS$1.9t18.3x31.9x2.8x
Sat, 30 Nov 2024US$63.7tUS$22.0tUS$1.9t19.6x33x2.9x
Mon, 28 Oct 2024US$60.2tUS$21.7tUS$1.9t18x32.2x2.8x
Wed, 25 Sep 2024US$59.2tUS$21.5tUS$1.9t18.2x31.8x2.7x
Fri, 23 Aug 2024US$57.9tUS$21.5tUS$1.8t17.8x31.4x2.7x
Sun, 21 Jul 2024US$57.2tUS$21.3tUS$1.8t17.7x31x2.7x
Tue, 18 Jun 2024US$56.1tUS$21.3tUS$1.8t16.7x30.5x2.6x
Thu, 16 May 2024US$54.3tUS$21.2tUS$1.8t17.5x30x2.6x
Sat, 13 Apr 2024US$54.1tUS$21.1tUS$1.8t16.6x29.2x2.6x
Mon, 11 Mar 2024US$53.4tUS$21.1tUS$1.8t16.5x29x2.5x
Wed, 07 Feb 2024US$51.5tUS$21.0tUS$1.8t16.2x29x2.4x
Fri, 05 Jan 2024US$49.2tUS$21.0tUS$1.8t16.7x28x2.3x
Sun, 03 Dec 2023US$48.1tUS$21.0tUS$1.8t16.2x27.5x2.3x
Tue, 31 Oct 2023US$43.6tUS$21.0tUS$1.7t14.8x25.1x2.1x
Thu, 28 Sep 2023US$45.1tUS$21.0tUS$1.7t15.3x26.3x2.2x
Sat, 26 Aug 2023US$46.3tUS$20.9tUS$1.7t15.6x27x2.2x
Mon, 24 Jul 2023US$48.0tUS$21.0tUS$1.7t15.7x28.7x2.3x
Wed, 21 Jun 2023US$46.4tUS$20.9tUS$1.7t15.2x27.9x2.2x
Fri, 19 May 2023US$44.3tUS$21.0tUS$1.7t14.8x26.6x2.1x
Sun, 16 Apr 2023US$43.6tUS$20.6tUS$1.6t15x26.9x2.1x
Tue, 14 Mar 2023US$41.0tUS$20.6tUS$1.6t14.5x25.2x2x
Thu, 09 Feb 2023US$44.2tUS$20.5tUS$1.7t15.4x25.9x2.2x
Sat, 07 Jan 2023US$41.5tUS$20.5tUS$1.8t14.5x23.2x2x
Price to Earnings Ratio

23.2x


Total Market Cap: US$41.5tTotal Earnings: US$1.8tTotal Revenue: US$20.5tTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Market Price to Earnings3Y Average 29.3x20242025
Current Market PE
  • Investors are relatively neutral on the American market at the moment, indicating that they expect earnings will grow in line with historical growth rates.
  • The market is trading at a PE ratio close to its 3-year average PE ratio of 29.3x.
Past Earnings Growth
  • The earnings for American listed companies have grown 8.5% per year over the last three years.
  • Revenues for these companies have grown 4.2% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Sector Trends

Which sectors have driven the changes within the U.S. Market?

US Market-0.48%
Real Estate0.95%
Energy0.90%
Utilities0.47%
Telecom0.16%
Consumer Staples0.15%
Healthcare-0.22%
Financials-0.59%
Tech-0.61%
Industrials-0.85%
Materials-0.90%
Consumer Discretionary-1.49%
Sector PE
  • Investors favour the Healthcare sector the most for future growth even though it's trading below its 3-year average PE ratio of 65.1x.
    • Analysts expect its future annual earnings growth (17.0%) to be largely in line with prior year's earnings growth.
    • The market's confidence could indicate that the market believes that analysts are underestimating future growth.
  • The Energy sector is the least preferred by investors for future growth. Although, investor sentiment seems to have improved given that it's trading above its 3-year average of 12.7x.
Forecasted Growth
  • Analysts are most optimistic on the Consumer Discretionary sector, expecting annual earnings growth of 20% over the next 5 years.
  • This is better than its past earnings decline of 0.5% per year.
  • In contrast, the Consumer Staples sector is expected to see its earnings grow by 10% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuationSector
LLY Eli LillyUS$1.08k0.8%
+US$7.3b		39.9%PE52.5xHealthcare
BRK.A Berkshire HathawayUS$755.40k0.6%
+US$7.0b		10.9%PE16.1xFinancials
MU Micron TechnologyUS$292.632.1%
+US$6.7b		247.7%PE27.7xTech
UNH UnitedHealth GroupUS$332.162.3%
+US$6.7b		-34.3%PE17.1xHealthcare
XOM Exxon MobilUS$120.991.3%
+US$6.6b		12.5%PE17xEnergy
See more

Market Insights

Header cover image
Three Sectors Expected to Rally in 2026 📈
With the backdrop of consistently strong broad market returns over the last few years, analysts are now looking at sector-specific plays that could outperform in 2026.
Continue reading
🤖 AI Companies Hit The Bond Market
Last Week

🤖 AI Companies Hit The Bond Market

Latest News

NVDA
US$187.54
NVIDIA
7D
-0.6%
1Y
39.7%
ORCL
US$197.21
Oracle
7D
1.0%
1Y
18.3%
JPM
US$323.42
JPMorgan Chase
7D
-0.8%
1Y
34.9%
LLY
US$1,079.75
Eli Lilly
7D
0.8%
1Y
39.9%

LLY: GLP-1 Pricing Deals And Policy Will Shape Future Obesity Leadership And Risks

Analysts have lifted their fair value estimate for Eli Lilly to approximately $1,093 from about $1,024, reflecting expectations for stronger long term GLP 1 driven revenue growth, expanding profit margins and sustained leadership in the obesity market, supported by recent U.S. reimbursement and pricing deals. Analyst Commentary Street research remains broadly constructive on Eli Lilly, with a series of upward price target revisions and fresh coverage initiations underscoring confidence in the durability of its GLP 1 franchise and broader innovation pipeline.
NKE
US$61.19
NIKE
7D
6.7%
1Y
-19.1%
BABA
US$147.36
Alibaba Group Holding
7D
-2.6%
1Y
73.8%

BABA: Cloud AI Monetization Will Drive Stronger Long-Term Earnings Power

Analysts made a marginal upward revision to their fair value estimate for Alibaba Group Holding to approximately $198 per share, reflecting slightly stronger long term cloud and artificial intelligence monetization prospects that more than offset modestly reduced revenue and profit forecasts tied to quick commerce and customer management headwinds. Analyst Commentary Street research on Alibaba remains broadly constructive, with a series of upward price target revisions anchored in improving cloud and artificial intelligence monetization, partly offset by concerns around near term profitability in quick commerce and customer management revenue.
INTC
US$37.30
Intel
7D
3.2%
1Y
86.0%

INTC: Foundry And AI Execution Will Drive Confidence In Turnaround Narrative

Analysts have lifted their Intel fair value estimate to about $52 from roughly $27, reflecting improving execution, early but encouraging foundry progress, and a clearer AI strategy, even as they continue to flag rich valuation and execution risk. Analyst Commentary Recent Street research reflects a more constructive, but still guarded, view on Intel as bullish analysts acknowledge improving execution and a clearer AI and foundry strategy.
MU
US$292.63
Micron Technology
7D
2.1%
1Y
247.7%
APP
US$693.71
AppLovin
7D
-4.6%
1Y
114.2%

Subdued Growth No Barrier To AppLovin Corporation (NASDAQ:APP) With Shares Advancing 31%

Dec 19
Subdued Growth No Barrier To AppLovin Corporation (NASDAQ:APP) With Shares Advancing 31%
UNH
US$332.16
UnitedHealth Group
7D
2.3%
1Y
-34.3%

UNH: Margin Recovery And Policy Risks Will Shape Earnings Trajectory

Analysts have raised their fair value estimate for UnitedHealth Group from $198.00 to approximately $304.61 as they factor in a sector wide margin recovery in Medicare Advantage and Medicaid, improved pricing discipline at Optum Health, and a higher forward price to earnings multiple reflecting expectations for significant EPS growth in the coming years. Analyst Commentary Recent Street research on UnitedHealth Group reflects a generally constructive outlook on earnings recovery and valuation, but with a growing emphasis on execution risk around Medicare Advantage repricing, regulatory changes, and the pace of Optum margin normalization.
PLTR
US$180.84
Palantir Technologies
7D
-6.9%
1Y
139.1%
XOM
US$120.99
Exxon Mobil
7D
1.3%
1Y
12.5%
AAPL
US$273.08
Apple
7D
-0.3%
1Y
9.0%
SHOP
US$163.74
Shopify
7D
-3.4%
1Y
54.0%

SHOP: AI Partnerships And Margin Expansion Will Drive Measured Upside Into 2025

Analysts have nudged our Shopify price target higher to approximately $175, up modestly from about $170. This reflects slightly faster expected profit margin expansion and durable post Q3 growth momentum that they believe supports the stock's premium valuation.
TSLA
US$454.43
Tesla
7D
-6.4%
1Y
12.5%

TSLA: AI And Autonomy Focus Will Deepen Risks From Weakening Core Demand

Analysts have modestly trimmed their Tesla price target to approximately $391 per share, reflecting slightly higher discount rates and marginally lower long term growth and margin assumptions, even as they continue to see meaningful upside from AI, autonomy and energy storage over time. Analyst Commentary Recent Street research on Tesla reflects a wide dispersion of views, with some firms leaning into the company’s AI and robotics optionality while others remain focused on execution risk in the core auto and capital intensity of the growth agenda.
BRK.A
US$755,400.00
Berkshire Hathaway
7D
0.6%
1Y
10.9%